Colgate-Palmolive India stock faces pressure as ad costs rise

Published on 11/01/2026 at 01:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Colgate-Palmolive India stock faces margin pressure after strong sales growth. Higher brand spending and competition are clouding the earnings outlook.

Growth Meets Margin Pressure

Colgate-Palmolive India reported 12.2 percent year-on-year revenue growth in its September quarter.
Higher advertising spending and stronger competition reduced operating profitability and led brokerages to lower earnings estimates.
Premium toothpaste products and volume growth remain central to the companys strategy as investors watch margins and demand.

Colgate, INE259A01022, Illustration mit AI erstellt.

Colgate-Palmolive India delivered double-digit sales growth in the September quarter, but higher brand investments and intensifying competition put pressure on profitability. Business Standard reported on October 23 that brokerages had reduced earnings estimates after the companys second-quarter results.

Sales Growth Tests Profitability

Revenue increased 12.2 percent year on year in the quarter, marking a second consecutive period of double-digit growth. The improvement was supported by high-single-digit volume growth, premium toothpaste and Colgate MaxFresh, although the comparison benefited from a weaker base in the first half of the previous fiscal year.

Gross margin expanded by 40 basis points to 69.9 percent, while advertising spending rose 40 percent year on year. The additional brand investment, together with higher employee and other expenses, weighed on operating profit growth. Elara Research cut its earnings estimates and assigned a reduce rating with a target price of 1,600 Indian rupees, according to the report.

Competition Raises Execution Risk

Colgate continues to emphasize premiumisation and innovation, while mass-market and natural oral-care products face stronger competitive pressure. Haleons announced capacity investment in India could add to the competitive intensity in categories that include Sensodyne and Parodontax. The key issue for investors is whether volume gains can offset the near-term cost of building brands.

Colgate-Palmolive India stock traded at 1,596.50 Indian rupees on the National Stock Exchange at 11:58 a.m. CEST on Friday, October 30.

Colgate-Palmolive India

Colgate-Palmolive India develops and sells oral-care products, including toothpaste and related consumer goods, through one of Indias broadest distribution networks. The company serves the Indian consumer market and has operated there since 1937. It holds a leading position in Indian oral care, while Haleon is a named competitor with brands such as Sensodyne and Parodontax. Colgates investment case therefore combines established distribution and premium products with the need to defend margins against rising competition.